These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 5110012

  • 1. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Lehrach F, Müller R.
    Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
    [No Abstract] [Full Text] [Related]

  • 2. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H.
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract] [Full Text] [Related]

  • 3. [Polygraphic registrations after parenteral administration of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Jovanović UJ.
    Arzneimittelforschung; 1972 Jun; 22(6):994-9. PubMed ID: 4559161
    [No Abstract] [Full Text] [Related]

  • 4. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
    Buckert D, Harwart D.
    Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
    [No Abstract] [Full Text] [Related]

  • 5. The influence of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (pentoxifylline, BL 191) on serum calcium and magnesium levels.
    Lossnitzer K, Raptis S, Grebe B, Müller R.
    Arzneimittelforschung; 1973 Jul; 23(7):938-40. PubMed ID: 4800449
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
    Prosenz P, Tschabitscher H.
    Wien Klin Wochenschr; 1965 Dec 03; 77(48):953-5. PubMed ID: 5331101
    [No Abstract] [Full Text] [Related]

  • 7. [Drug therapy of peripheral arterial blood circulation disorders].
    Bollinger A.
    Dtsch Med Wochenschr; 1969 Nov 07; 94(45):2347-9. PubMed ID: 5346859
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of vasodilator agents on oral glucose tolerance and serum insulin in intravenous long-term treatment of blood circulation disorders involving peripheral arteries].
    Heidrich H, Schirop T.
    Verh Dtsch Ges Inn Med; 1975 Nov 07; 81():1496-7. PubMed ID: 818839
    [No Abstract] [Full Text] [Related]

  • 9. [When are vasodilator agents effective in arterial occlusive diseases? Plethysmographic measurements in a double blind trial].
    Baitsch G, Schäfer M.
    Med Welt; 1969 Aug 30; 35():1910-3. PubMed ID: 4897422
    [No Abstract] [Full Text] [Related]

  • 10. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R.
    Fortschr Med; 1972 Aug 31; 90(24):865-72. PubMed ID: 4639351
    [No Abstract] [Full Text] [Related]

  • 11. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
    Bollinger A, Lüthy E.
    Helv Med Acta Suppl; 1967 May 28; 47():128. PubMed ID: 5286297
    [No Abstract] [Full Text] [Related]

  • 12. [Toxicity of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine in animal experiment].
    Schultes E, Popendiker K, Doerr BI, Leuschner F.
    Arzneimittelforschung; 1971 Oct 28; 21(10):1446-53. PubMed ID: 5171858
    [No Abstract] [Full Text] [Related]

  • 13. [Ophthalmological experiences with the xanthine compound BL 191 (author's transl)].
    Heinsius E, Flamm P.
    Med Klin; 1973 Nov 23; 68(47):1540-8. PubMed ID: 4781096
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetics of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man].
    Hinze HJ.
    Arzneimittelforschung; 1972 Sep 23; 22(9):1492-5. PubMed ID: 4678611
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
    Krakovskij NI, Taranovic VA.
    Arzneimittelforschung; 1970 Oct 23; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
    [No Abstract] [Full Text] [Related]

  • 16. [Pulmonary function tests on the bronchospasmolytic effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Nolte D.
    Arzneimittelforschung; 1971 Oct 23; 21(10):1453-6. PubMed ID: 5171859
    [No Abstract] [Full Text] [Related]

  • 17. Vascular diseases: new results with pentoxifylline.
    Belcaro G, Cesarone MR, Ippolito E.
    Angiology; 2002 Oct 23; 53 Suppl 1():1 p following TOC. PubMed ID: 11863316
    [No Abstract] [Full Text] [Related]

  • 18. [Ophthalmological use of bencyclane and ophthalmodynamometric recording of its effect on cerebral vessels].
    Födö V.
    Arzneimittelforschung; 1970 Oct 23; 20(10):Suppl 10a:1450+. PubMed ID: 5536669
    [No Abstract] [Full Text] [Related]

  • 19. Proceedings: Pharmacological effects of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (BL 191).
    Sakurai M, Kitatani T, Nagato K, Sakaguchi T.
    Jpn J Pharmacol; 1974 Oct 23; 24(0):s:68. PubMed ID: 4546078
    [No Abstract] [Full Text] [Related]

  • 20. [Value of drugs acting on the smooth musculature by direct and indirect routes in therapy of vascular diseases].
    Labò G, Pretolani E.
    Cardiol Prat; 1971 Feb 23; 22(1):1-9. PubMed ID: 4398064
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.